Acelot will present at CDD Vault event
Lewis Whitehead will share perspectives on overcoming challenges with elusive targets.
See the latest news and media coverage for Acelot. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotech developing small molecules for neurodegenerative diseases
acelot.comLast updated
Lewis Whitehead will share perspectives on overcoming challenges with elusive targets.
CEO Dr. Katie Planey speaks on October 8th at 2pm ET in Florida. Poster 151 follows on October 9th. FIH trials start next year.
Highlighted in their report on companies targeting TDP-43 dysfunction in ALS. Innovates in therapeutic development and TDP-43 quantification methods.
Track Acelot and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Acelot and other trending companies.